AIMS/HYPOTHESIS: Although protective relationships between coffee consumption and type 2 diabetes mellitus have consistently been observed, few studies have examined the relationships between coffee consumption and underlying pathophysiological defects that characterise diabetes aetiology. The aim of this study was to explore the associations between caffeinated and decaffeinated coffee consumption and measures of insulin sensitivity and secretion. METHODS: The study population included 954 multi-ethnic non-diabetic adults from the Insulin Resistance Atherosclerosis Study (IRAS). Multiple regression analyses were performed to examine the cross-sectional relationships between caffeinated and decaffeinated coffee intake and insulin sensitivity and acute insulin response, measured by a frequently sampled intravenous glucose tolerance test, 2 h postload glucose measured by OGTT, fasting insulin, and proinsulin to C-peptide ratios. RESULTS: Caffeinated coffee intake was positively associated with insulin sensitivity (β = 0.054; SE = 0.026; p = 0.04) and inversely related to 2 h postload glucose (β = -0.37; SE = 0.10; p = 0.0003) in fully adjusted models. Caffeinated coffee intake was not associated with acute insulin response or proinsulin ratios. Decaffeinated coffee intake was inversely related to 2 h postload glucose (β = -0.47; SE = 0.18; p = 0.0096) and positively related to acute insulin response (β = 0.191; SE = 0.077; p = 0.0132). Decaffeinated coffee intake was inversely related to the ratios of both intact and split proinsulin to C-peptide (β = -0.150; SE = 0.061; p = 0.0148; β = -0.254; SE = 0.068; p = 0.0002, respectively). CONCLUSIONS/ INTERPRETATION: In this cross-sectional study, caffeinated coffee was positively related to insulin sensitivity and decaffeinated coffee was favourably related to measures of beta cell function. These results provide pathophysiological insight as to how coffee could impact the risk of type 2 diabetes mellitus.
AIMS/HYPOTHESIS: Although protective relationships between coffee consumption and type 2 diabetes mellitus have consistently been observed, few studies have examined the relationships between coffee consumption and underlying pathophysiological defects that characterise diabetes aetiology. The aim of this study was to explore the associations between caffeinated and decaffeinated coffee consumption and measures of insulin sensitivity and secretion. METHODS: The study population included 954 multi-ethnic non-diabetic adults from the Insulin Resistance Atherosclerosis Study (IRAS). Multiple regression analyses were performed to examine the cross-sectional relationships between caffeinated and decaffeinated coffee intake and insulin sensitivity and acute insulin response, measured by a frequently sampled intravenous glucose tolerance test, 2 h postload glucose measured by OGTT, fasting insulin, and proinsulin to C-peptide ratios. RESULTS:Caffeinated coffee intake was positively associated with insulin sensitivity (β = 0.054; SE = 0.026; p = 0.04) and inversely related to 2 h postload glucose (β = -0.37; SE = 0.10; p = 0.0003) in fully adjusted models. Caffeinated coffee intake was not associated with acute insulin response or proinsulin ratios. Decaffeinated coffee intake was inversely related to 2 h postload glucose (β = -0.47; SE = 0.18; p = 0.0096) and positively related to acute insulin response (β = 0.191; SE = 0.077; p = 0.0132). Decaffeinated coffee intake was inversely related to the ratios of both intact and split proinsulin to C-peptide (β = -0.150; SE = 0.061; p = 0.0148; β = -0.254; SE = 0.068; p = 0.0002, respectively). CONCLUSIONS/ INTERPRETATION: In this cross-sectional study, caffeinated coffee was positively related to insulin sensitivity and decaffeinated coffee was favourably related to measures of beta cell function. These results provide pathophysiological insight as to how coffee could impact the risk of type 2 diabetes mellitus.
Authors: Andrew O Odegaard; Mark A Pereira; Woon-Puay Koh; Kazuko Arakawa; Hin-Peng Lee; Mimi C Yu Journal: Am J Clin Nutr Date: 2008-10 Impact factor: 7.045
Authors: Lesley L Moisey; Sita Kacker; Andrea C Bickerton; Lindsay E Robinson; Terry E Graham Journal: Am J Clin Nutr Date: 2008-05 Impact factor: 7.045
Authors: Ting Yang; Xiang Gao; Monica Sandberg; Christa Zollbrecht; Xing-Mei Zhang; Michael Hezel; Ming Liu; Maria Peleli; En-Yin Lai; Robert A Harris; A Erik G Persson; Bertil B Fredholm; Leif Jansson; Mattias Carlström Journal: Diabetologia Date: 2015-04-03 Impact factor: 10.122
Authors: Teresa T Fung; Frank B Hu; Matthias Schulze; Michael Pollak; Tianying Wu; Charles S Fuchs; Edward Giovannucci Journal: Cancer Causes Control Date: 2012-04-26 Impact factor: 2.506
Authors: Yash R Patel; Taraka V Gadiraju; R Curtis Ellison; Steven C Hunt; John Jeffrey Carr; Gerardo Heiss; Donna K Arnett; James S Pankow; J Michael Gaziano; Luc Djoussé Journal: Clin Nutr ESPEN Date: 2017-01-01
Authors: Shilpa N Bhupathiraju; An Pan; Vasanti S Malik; JoAnn E Manson; Walter C Willett; Rob M van Dam; Frank B Hu Journal: Am J Clin Nutr Date: 2012-11-14 Impact factor: 7.045
Authors: Anthony Zulli; Renee M Smith; Peter Kubatka; Jan Novak; Yoshio Uehara; Hayley Loftus; Tawar Qaradakhi; Miroslav Pohanka; Nazarii Kobyliak; Angela Zagatina; Jan Klimas; Alan Hayes; Giampiero La Rocca; Miroslav Soucek; Peter Kruzliak Journal: Eur J Nutr Date: 2016-03-01 Impact factor: 5.614
Authors: Marc J Gunter; Neil Murphy; Amanda J Cross; Laure Dossus; Laureen Dartois; Guy Fagherazzi; Rudolf Kaaks; Tilman Kühn; Heiner Boeing; Krasimira Aleksandrova; Anne Tjønneland; Anja Olsen; Kim Overvad; Sofus Christian Larsen; Maria Luisa Redondo Cornejo; Antonio Agudo; María José Sánchez Pérez; Jone M Altzibar; Carmen Navarro; Eva Ardanaz; Kay-Tee Khaw; Adam Butterworth; Kathryn E Bradbury; Antonia Trichopoulou; Pagona Lagiou; Dimitrios Trichopoulos; Domenico Palli; Sara Grioni; Paolo Vineis; Salvatore Panico; Rosario Tumino; Bas Bueno-de-Mesquita; Peter Siersema; Max Leenders; Joline W J Beulens; Cuno U Uiterwaal; Peter Wallström; Lena Maria Nilsson; Rikard Landberg; Elisabete Weiderpass; Guri Skeie; Tonje Braaten; Paul Brennan; Idlir Licaj; David C Muller; Rashmi Sinha; Nick Wareham; Elio Riboli Journal: Ann Intern Med Date: 2017-07-11 Impact factor: 25.391